title: [Results of the treatment of patients with advanced lung cancer with the combination of methotrexate, adriamycin, cyclophosphamide and CCNU (MACC)].
authors.forename: B
authors.initials: B
authors.lastname: Lisowska
authors.forename: K
authors.initials: K
authors.lastname: Krawczyk
authors.forename: M
authors.initials: M
authors.lastname: Krochmal
mesh_terms: D000328:Adult; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D003520:Cyclophosphamide / Q000008:administration & dosage; D004317:Doxorubicin / Q000008:administration & dosage; D006801:Humans; D008130:Lomustine / Q000008:administration & dosage; D008175:Lung Neoplasms / Q000188:drug therapy* / Q000473:pathology; D008297:Male; D008727:Methotrexate / Q000008:administration & dosage; D008875:Middle Aged; D009367:Neoplasm Staging
chemical_list: D008130:Lomustine; D004317:Doxorubicin; D003520:Cyclophosphamide; D008727:Methotrexate
vernacular_title: Wyniki leczenia chorych na zaawansowanego raka płuca skojarzeniem metotreksatu, adriamycyny, cyklofosfamidu i CCNU/MACC.